MIV Therapeutics Highlights Its Innovative Biomedical Technology in New Internet Presentation
5th Sep 2005, 14:35 GMT
MIV Therapeutics, a developer of next-generation biocompatible stent coatings and drug delivery technologies, announced the online availability of a new corporate presentation highlighting its pioneering technologies engineered to enhance the therapeutic performance of cardiovascular stents and other medical devices.
Latest news from Angiography/ Cardiac Cath News from myHealthcareNews.com:
- Thinking Systems Releases Enhanced PET-CT Functions for Its ThinkingPACS
- Tallahassee Memorial Hospital at the Forefront in Treatment of Heart Attack Patients
- Preliminary Long-Term Clinical Data Show Promising Results for the CYPHER Sirolimus-eluting Coronary Stent in Patients With Multi-Vessel Disease